About Rebif (Prescription Drug)
Rebif®, a brand name for interferon beta-1a, is used to prevent relapses and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It is given subcutaneously (under the skin) three times a week, ideally the same 3 days each week.
Learn more about Rebif in our Rebif Community Report.
|Rebif (interferon beta-1a subq injection)|
|3 x 44 mcg/0.5 mL Weekly May 15, 2008 - Mar 17, 2010|
|Stopped Doctor's advice Mar 17, 2010|
Mar 17, 2010
EffectivenessSlight (for multiple sclerosis)
BurdenNot at all hard to take